Ashwagandha KSM-66: What it is and how it differs

September 22, 2026

Ashwagandha has a long history of traditional use, but modern products vary considerably in plant part, extraction method, strength and quality. This guide explains what makes KSM-66® different, what scientists have investigated and how to use Nutrition A2Z Ashwagandha KSM-66® responsibly.

What is ashwagandha, where is it grown and how long has it been used?

Ashwagandha, botanically known as Withania somnifera, is a small shrub associated particularly with India, although the plant also grows across parts of South Asia, the Middle East and Africa. It favours relatively dry conditions and is cultivated commercially in several regions of India.

The roots used to produce KSM-66® are cultivated on farms in Rajasthan, northern India. Rajasthan’s relatively dry climate and growing conditions are well suited to ashwagandha cultivation. KSM-66® operates a vertically controlled supply chain covering cultivation, root selection, extraction and standardisation, helping maintain the identity and consistency of the branded ingredient.

Ashwagandha has been documented within Ayurveda and other traditional Indian practices for more than 3,000 years. It was traditionally classified as a rasayana—a preparation associated historically with nourishment, restoration and vitality. Its roots were used in traditional preparations for a wide variety of purposes.

This long history helps explain ashwagandha’s cultural importance, but traditional use should not be confused with modern clinical proof. Present-day scientific research must still assess a clearly identified extract, dose, participant group and period of use. Nutrition A2Z therefore distinguishes between historical use and findings from controlled human studies.

What makes KSM-66® different?

KSM-66® is a proprietary, root-only ashwagandha extract rather than ordinary powdered root or an unidentified root-and-leaf mixture. It is produced through a controlled extraction process and standardised to provide a consistent amount of withanolides. Standardisation matters because two capsules displaying the same total milligram amount may not contain the same concentration or profile of plant compounds.

Nutrition A2Z’s certificate of analysis confirms that each capsule contains 500 mg of KSM-66® ashwagandha root extract, equivalent to 6,250 mg of ashwagandha root and providing 25 mg of withanolides. This represents a 5% withanolide concentration. KSM-66® has also been used in a number of published human trials, allowing its particular extract to be identified rather than treating every form of ashwagandha as identical.

What have human studies investigated?

Researchers have investigated standardised ashwagandha extracts in relation to perceived stress, sleep, physical performance, muscle strength, endurance, concentration and aspects of male reproductive health. KSM-66® has been used in several of these trials, although other studies have used different extracts, doses and preparations.

A study result should not be interpreted as a guaranteed outcome for every person. Many ashwagandha trials have involved relatively small participant groups and short study periods, and some have been connected to ingredient manufacturers. Differences in the extract, dose, participant health and study design also make direct comparisons difficult. The research is useful for understanding why ashwagandha is being studied, but it does not make the supplement a treatment for a medical condition.

What does the research say about stress and emotional wellbeing?

Several controlled trials have studied ashwagandha in adults reporting elevated stress. Some trials using standardised root extracts reported changes in participant questionnaires and biological measurements compared with placebo. A subsequent systematic review and meta-analysis also found favourable results, but rated the certainty of evidence as low because the studies varied considerably and were generally small.

This means that research into stress is promising but not conclusive. Nutrition A2Z Ashwagandha KSM-66® must not be presented as treating anxiety, depression, chronic stress or another mental-health condition. Anyone experiencing persistent anxiety, low mood, panic, trauma symptoms or severe stress should seek appropriate professional support rather than relying on a food supplement.

What does the research say about sleep?

A systematic review examined five controlled trials involving approximately 400 adults. Four of the five trials used KSM-66® root extract. The combined findings indicated a small improvement in overall sleep measurements compared with placebo, with more noticeable findings in some studies using at least 600 mg daily for eight weeks or longer.

These findings require perspective. The trials used different sleep measurements, participant groups and doses, and the review identified inconsistency and small sample sizes. Evidence concerning long-term use and serious adverse effects was also limited. Ashwagandha should therefore not be described as a sleeping medicine or a treatment for insomnia. People with persistent sleep problems should speak with a healthcare professional so that possible underlying causes can be assessed.

What does the research say about exercise, strength and recovery?

KSM-66® has been investigated alongside resistance training. In one eight-week placebo-controlled trial involving relatively inexperienced male participants, the group receiving 300 mg twice daily alongside a training programme recorded greater changes in selected strength and body-composition measurements than the placebo group. Other small studies have investigated cardiorespiratory endurance and exercise performance.

These studies are interesting, but they do not show that taking ashwagandha alone builds muscle. Resistance training provides the principal stimulus for muscle development. Sufficient protein, total energy intake, sleep, recovery and a well-designed training programme remain fundamental. Ashwagandha must not replace these foundations, and the available research does not establish that every user will experience greater strength, muscle growth or faster recovery.

Which age groups and genders have been studied?

Nutrition A2Z Ashwagandha KSM-66® is formulated for adults. Most modern ashwagandha trials have involved adults between approximately 18 and 60 years of age. Both men and women have participated in research concerning perceived stress and sleep, so these subjects are not limited to one gender. However, individual responses vary and the evidence does not prove that every adult will benefit.

Young and middle-aged adults

Most research has been conducted in young or middle-aged adults. Studies have investigated subjects including perceived stress, sleep, exercise performance and general wellbeing. This means the evidence is most directly relevant to adults within these age ranges, although the trials remain relatively small and short.

Older adults

A small number of trials have included adults aged 60 and over. One sleep study involved healthy older participants whose average age was approximately 72 years. The available evidence for older people is much more limited than for younger adults. Older adults are also more likely to take regular medication or have medical conditions, so they should consult a doctor or pharmacist before using ashwagandha.

Men

Research involving men has examined resistance training, strength, endurance, sexual wellbeing, testosterone measurements and semen quality. Some studies reported favourable changes, but these findings do not establish ashwagandha as a treatment for low testosterone, erectile dysfunction or infertility. Men with hormonal, fertility, sexual-health or prostate concerns should seek medical assessment.

Women

Women have been included in several studies concerning stress and sleep, and separate research has examined aspects of female sexual wellbeing using particular ashwagandha extracts. Evidence specifically concerning women remains limited, and results obtained with another extract should not automatically be attributed to KSM-66®. Women who are pregnant, trying to become pregnant or breastfeeding should not use ashwagandha without explicit medical advice.

Children and teenagers

This product is not intended for children or teenagers. There is insufficient high-quality evidence to establish an appropriate dose or long-term safety for younger age groups. Parents should not adapt the adult serving for a child unless advised by a suitably qualified healthcare professional.

Who is most likely to benefit?

Research does not allow us to identify a particular age or gender that is guaranteed to benefit. Ashwagandha has primarily been studied in adults, and suitability depends on health, medication, the reason for considering supplementation and the particular extract and dose used. The responsible approach is to follow the product label, assess individual tolerance and seek professional advice where appropriate.

How strong is Nutrition A2Z Ashwagandha KSM-66®?

Each vegan capsule provides 500 mg of KSM-66® root extract. The product’s certificate of analysis confirms that this is equivalent to 6,250 mg of ashwagandha root and provides 25 mg of withanolides. Two capsules would provide 1,000 mg of extract and 50 mg of withanolides.

A larger amount is not automatically more suitable or more effective. Research studies have used various doses, frequently around 500 to 600 mg daily, but study doses should not be used to override the directions printed on a commercial product. Individual responses and tolerability differ, and customers should always remain within the labelled serving.

The product contains KSM-66® root extract, brown rice flour and a vegan hydroxypropyl methylcellulose capsule shell. It is manufactured in the United Kingdom according to GMP requirements and is formulated for adults.

How much should you take and when?

The Nutrition A2Z product directions advise adults to take one or two capsules with food and water. Do not exceed the recommended daily amount. Someone beginning the product may prefer to start with one capsule to assess personal tolerance rather than automatically taking the maximum serving.

There is no universally proven best time. A capsule may be taken with breakfast or lunch if it fits naturally into a daytime routine. Some people prefer an evening serving, particularly because ashwagandha can cause drowsiness in certain individuals. Anyone who feels unusually sleepy should avoid driving, operating machinery or combining it with alcohol or sedative products.

Consistency is more relevant to the research than taking a capsule at an exact time. Most studies examined daily use over several weeks rather than an immediate effect from a single dose. Do not increase the amount in an attempt to obtain faster results.

Who should avoid ashwagandha or seek professional advice?

Ashwagandha is intended for adults. It should not be used during pregnancy or breastfeeding. Anyone with a medical condition, awaiting surgery, receiving medical treatment or taking regular medication should consult a doctor or pharmacist before use.

Particular caution is appropriate for people with thyroid disorders, autoimmune conditions, liver disease, diabetes, low blood pressure, stomach ulcers or hormone-sensitive prostate cancer. Ashwagandha may interact with thyroid medicines, diabetes medicines, blood-pressure medicines, sedatives, anticonvulsants and medicines that suppress the immune system.

Reported unwanted effects can include stomach discomfort, nausea, diarrhoea, vomiting and drowsiness. Rare cases of liver injury have also been associated with ashwagandha supplements. Stop using the product and seek prompt medical advice if symptoms such as yellowing of the skin or eyes, dark urine, unusual itching, severe tiredness, persistent nausea or abdominal pain develop. Evidence about continuous long-term use remains limited.

Food supplements should not replace a varied, balanced diet and healthy lifestyle. Keep the product out of the reach of children and follow the storage instructions on the packaging.

Why choose Nutrition A2Z KSM-66®?

Nutrition A2Z Ltd is officially licensed to use the KSM-66® trademark in connection with the promotion, distribution and sale of its Ashwagandha KSM-66® product. This helps distinguish the product from supplements containing an unspecified generic powder or an extract whose identity and strength are unclear.

Each vegan capsule provides a documented 500 mg of genuine KSM-66® root extract, equivalent to 6,250 mg of ashwagandha root and standardised to provide 25 mg of Withanolides. The branded ingredient, certificate of analysis, licensed supply chain and UK GMP manufacture provide customers with greater confidence in the identity, strength, consistency and traceability of the product.

Nutrition A2Z believes that responsible supplementation begins with clear information. Our aim is to explain both the areas being investigated and the limitations of the evidence, allowing customers to make better-informed decisions without exaggerated promises.

Explore Nutrition A2Z Ashwagandha KSM-66®

Each vegan capsule provides 500 mg of KSM-66® Ashwagandha root extract, standardised to 5% withanolides. Nutrition A2Z is licensed to use the KSM-66® trademark for this product.